Patient perceptions of cardiovascular risk, lipid management and statins in type 1 diabetes

被引：1

作者：

Lan, Nick S. R. ^{[1
,3
,7
]}

Hong, Regina S. Y. ^{[1
,2
]}

Ryan, Christopher ^{[4
]}

Jenkins, Alicia J. ^{[5
,6
]}

Fegan, P. Gerry ^{[1
]}

机构：

[1] Fiona Stanley Hosp, Dept Endocrinol & Diabet, Murdoch, WA, Australia

[2] Fiona Stanley Hosp, Dept Cardiol, Murdoch, WA, Australia

[3] Univ Western Australia, Med Sch, Crawley, WA, Australia

[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

[5] Baker IDI Heart & Diabet Inst, Melbourne, Australia

[6] Curtin Univ, Med Sch, Perth, WA, Australia

[7] Fiona Stanley Hosp, Dept Endocrinol & Diabet, 11 Robin Warren Dr, Murdoch, WA 6150, Australia

来源：

PRIMARY CARE DIABETES | 2023年 / 17卷 / 05期

关键词：

Diabetes mellitus type 1; Cardiovascular diseases; Dyslipidaemias; Statins; Risk factors; ADULTS;

D O I：

10.1016/j.pcd.2023.07.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Lipid-lowering reduces cardiovascular risk in type 1 diabetes (T1D), but dyslipidaemia remains under-recognised and under-treated. Through patient surveys, barriers to lipid management in T1D were identified, including lack of awareness of cardiovascular risk and cholesterol levels, preference for managing glycaemia over lipids, preference for lifestyle modification over pharmacotherapy, and statin side-effect concerns.

引用

页码：526 / 528

页数：3

共 50 条

[21] Assessing cardiovascular risk in Type 1 diabetes
Schofield, J. D.
Liu, Y.
Siahmansur, T.
Pemberton, P.
Hobkirk, J.
Stevens, A.
Whitelaw, D.
Carroll, S.
Malik, R.
Soran, H.
DIABETIC MEDICINE, 2017, 34 : 51 - 51
[22] Cardiovascular Risk in Type 1 Diabetes Mellitus
Jonathan Schofield
Jan Ho
Handrean Soran
Diabetes Therapy, 2019, 10 : 773 - 789
[23] Cardiovascular disease risk in type 1 diabetes
Anagnostis, Panagiotis
Godsland, Ian F.
Lancet Diabetes & Endocrinology, 2015, 3 (05): : 316 - 317
[24] Type 1 diabetes mellitus and cardiovascular risk
Jose Chillaron, Juan
Francisco Cano, Juan
Pedro-Botet, Juan
CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS, 2008, 20 (05): : 210 - 217
[25] Type-1-Diabetes and Cardiovascular Risk
不详
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2021, 146 (06)
[26] Trends in Cardiovascular Risk Factor Management in Type 1 Diabetes (T1D)
Swasey, Krystal Kapi'Olani
Costacou, Tina
Arena, Vincent C.
Orchard, Trevor J.
DIABETES, 2016, 65 : A366 - A366
[27] Type 2 diabetes mellitus in adolescence: Lipid and cardiovascular risk factors
Kenneth Lee Jones
Asheesh Kumar Dewan
Current Diabetes Reports, 2003, 3 (3) : 255 - 262
[28] Diabetes and lipid lowering: where are we? We are now sure that statins cut cardiovascular risks in type 2 diabetes
Reckless, John P. D.
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7550): : 1103 - 1104
[29] Management of a patient at high risk of type 2 diabetes
Howells, Lara
McKay, Ailsa J.
Hussain, Sufyan
Majeed, Azeem
LONDON JOURNAL OF PRIMARY CARE, 2016, 8 (05) : 76 - 79
[30] Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
Varkevisser, Rita Delphine Maiko
Birnie, Erwin
Vollenbrock, Charlotte E.
Mul, Dick
van Dijk, Peter R.
van der Klauw, Melanie M.
Veeze, Henk
Wolffenbuttel, Bruce H. R.
Aanstoot, Henk-Jan
BMJ OPEN DIABETES RESEARCH & CARE, 2022, 10 (04)

← 1 2 3 4 5 →